Board exams, whether Class 10 or Class 12, are a milestone in every student’s academic journey. They not only assess knowledge but also influence future opportunities in higher education and careers.
Nearly one in ten people over the age of 70 have Alzheimer’s disease dementia, shows a first-of-its-kind study that paired blood-based markers and clinical assessments to study the disease in Norway 1 ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
Guardant Health is touting the results of a new study showing its Reveal blood test can detect whether chemotherapy is failing months before evidence shows up on regular scans, allowing oncologists to ...
We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. This article has ...
We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. This article has ...
CBSE Class 10 Study Plan: The CBSE Class 10 Board Exams 2026 will begin on 17 February 2026 with Mathematics, followed by English (21 Feb), Science (25 Feb), Hindi (2 Mar), and Social Science (7 Mar).
Exams require more than memorization, they demand strategy, balance, and resilience. From starting early and using active learning to maintaining mental health, nutrition, and exercise, these ten ...
If you are sitting any external assessments this year, your school will receive a printed copy of the Student Exam Guide to give to you at the start of Term 4. An electronic copy of the 2025 Student ...
A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved their quality of life. By Gina Kolata Breast cancer patients whose tumors have ...
NEWARK, Calif. & OSAKA, Japan & CAMBRIDGE, Mass., June 01, 2025--(BUSINESS WIRE)--Protagonist Therapeutics, Inc. ("Protagonist") (NASDAQ:PTGX) and Takeda (TSE:4502 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results